Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zepp Health (ZEPP) Research & Development: 2015-2024

Historic Research & Development for Zepp Health (ZEPP) over the last 10 years, with Dec 2024 value amounting to $46.2 million.

  • Zepp Health's Research & Development rose 0.52% to -$10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.4 million, marking a year-over-year increase of 1.78%. This contributed to the annual value of $46.2 million for FY2024, which is 10.38% down from last year.
  • Latest data reveals that Zepp Health reported Research & Development of $46.2 million as of FY2024, which was down 10.38% from $51.5 million recorded in FY2023.
  • Zepp Health's Research & Development's 5-year high stood at $82.5 million during FY2020, with a 5-year trough of $46.2 million in FY2024.
  • Moreover, its 3-year median value for Research & Development was $51.5 million (2023), whereas its average is $58.3 million.
  • In the last 5 years, Zepp Health's Research & Development skyrocketed by 33.24% in 2020 and then slumped by 33.37% in 2023.
  • Over the past 5 years, Zepp Health's Research & Development (Yearly) stood at $82.5 million in 2020, then fell by 1.97% to $80.8 million in 2021, then fell by 4.37% to $77.3 million in 2022, then crashed by 33.37% to $51.5 million in 2023, then decreased by 10.38% to $46.2 million in 2024.